![Mary Szela](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mary Szela
Directeur Général chez
TRISALUS LIFE SCIENCES, INC.
Fortune : 4 M $ au 31/10/2026
Profil
Ms. Mary T.
Szela is an Independent Director at Kura Oncology, Inc., a President, Chief Executive Officer & Director at TriSalus Operating Life Sciences, Inc. and a President, Chief Executive Officer & Director at TriSalus Life Sciences, Inc. She is on the Board of Directors at Absci Corp., Kura Oncology, Inc., TriSalus Operating Life Sciences, Inc., TriSalus Life Sciences, Inc., Court Appointed Special Advocates of Lake County and Sail Biomedicines Inc. Ms. Szela was previously employed as an Independent Director by Averin Capital Acquisition Corp., an Independent Director by Prometheus Biosciences, Inc., an Independent Director by Omega Therapeutics, Inc., an Independent Director by Alimera Sciences, Inc., a Chief Executive Officer & Director by Aegerion Pharmaceuticals, Inc., a Chief Executive Officer & Director by Novelion Therapeutics, Inc., an Independent Director by Coherus BioSciences, Inc., an Independent Director by Receptos, Inc., an Independent Director by Novo Nordisk A/S, a Co-Chief Executive Officer & Director by Melinta Therapeutics, Inc. /Old/, a Senior Vice President by US Pharmaceuticals, Inc., and a SVP-Global Strategic Marketing & Services by Abbott Laboratories.
She also served on the board at Senda Biosciences, Inc., Zikani Therapeutics, Inc., Suneva Medical, Inc. and Zikani Therapeutics, Inc. She received her undergraduate degree from the University of Illinois and an MBA from the University of Illinois.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/10/2026 | 1 074 990 ( 1,75 % ) | 4 M $ | 31/10/2026 | |
ABSCI CORPORATION 0,01 % | 30/06/2026 | 21 300 ( 0,01 % ) | 237 069 $ | 31/10/2026 |
KURA ONCOLOGY, INC. -.--% | 04/06/2026 | 0 ( -.--% ) | - $ | 31/10/2026 |
Postes actifs de Mary Szela
| Sociétés | Poste | Début |
|---|---|---|
| TRISALUS LIFE SCIENCES, INC. | Directeur Général | 01/01/2018 |
| KURA ONCOLOGY, INC. | Directeur/Membre du Conseil | 06/11/2018 |
| ABSCI CORPORATION | Directeur/Membre du Conseil | 07/07/2025 |
TriSalus Operating Life Sciences, Inc.
 TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for treatment of liver and pancreatic tumors | Directeur Général | 23/01/2018 |
Court Appointed Special Advocates of Lake County
 Court Appointed Special Advocates of Lake County Miscellaneous Commercial ServicesCommercial Services Operates as civic and social organization | Directeur/Membre du Conseil | - |
Sail Biomedicines
 Sail Biomedicines Pharmaceuticals: MajorHealth Technology Engages in design and deployment of programmable medicines | Directeur/Membre du Conseil | - |
Anciens postes connus de Mary Szela
| Sociétés | Poste | Fin |
|---|---|---|
| OMEA THER | Directeur/Membre du Conseil | 01/01/2025 |
| PROMETHEUS BIOSCIENCES, INC. | Directeur/Membre du Conseil | 16/06/2023 |
| COHERUS ONCOLOGY, INC. | Directeur/Membre du Conseil | 05/08/2021 |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Mary Szela
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
83
Relations au 1er degré
21
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 21 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Alimera Sciences, Inc.
 Alimera Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops, manufactures and commercializes therapeutics for ophthalmology, rheumatology, nephrology, neurology & pulmonology problems | Health Technology |
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases | Health Technology |
Receptos LLC
 Receptos LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapeutics in immune disease | Health Technology |
Kura Oncology, Inc.
 Kura Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Zikani Therapeutics, Inc.
 Zikani Therapeutics, Inc. Drugstore ChainsRetail Trade Focuses on the discovery and development of novel macrolide antibiotics for the treatment of life-threatening bacterial infections caused by drug resistant pathogens | Retail Trade |
University of Illinois
 University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Melinta Subsidiary Corp.
 Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Health Technology |
US Pharmaceuticals, Inc.
 US Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes medicines | Health Technology |
TriSalus Operating Life Sciences, Inc.
TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for treatment of liver and pancreatic tumors | Health Technology |
Suneva Medical, Inc.
 Suneva Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and commercializes novel, differentiated aesthetic products | Electronic Technology |
Coherus BioSciences, Inc.
 Coherus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage biopharmaceutical company that engages in research, development and commercialization of immunotherapies to treat cancer | Health Technology |
Court Appointed Special Advocates of Lake County
Court Appointed Special Advocates of Lake County Miscellaneous Commercial ServicesCommercial Services Operates as civic and social organization | Commercial Services |
Absci Corp.
 Absci Corp. BiotechnologyHealth Technology Engages in development of cutting-edge protein production technologies committed to reducing costs in the biopharmaceutical industry | Health Technology |
Novelion Therapeutics, Inc.
 Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets rare disease products, metreleptin and lomitapide | Health Technology |
Prometheus Biosciences, Inc.
 Prometheus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops medicines for immune-mediated diseases | Health Technology |
Omega Therapeutics, Inc.
 Omega Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for general and rare genetic diseases, immunology, inflammation, oncology and metabolic diseases | Health Technology |
Senda Biosciences, Inc.
 Senda Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics to treat diseases | Health Technology |
TriSalus Life Sciences, Inc.
 TriSalus Life Sciences, Inc. Medical SpecialtiesHealth Technology Engages in research, development and sales of innovative drug delivery technology & immune-oncology therapeutics | Health Technology |
Sail Biomedicines
Sail Biomedicines Pharmaceuticals: MajorHealth Technology Engages in design and deployment of programmable medicines | Health Technology |
